Literature DB >> 16277011

Diagnostic accuracy of MRI for preoperative staging of pancreatic carcinoma: tendency for understaging.

T A Bley1, M Uhl, P Simon, J Mayerle, N A Ghanem, B Geml, U Saueressig, M Langer.   

Abstract

OBJECTIVE: To evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) for preoperative staging in pancreatic carcinoma.
MATERIALS AND METHODS: MRI investigations, including MR-angio and MR-cholangiopancreatography (MRCP) of 19 patients who underwent surgery for pancreatic carcinoma were retrospectively evaluated by two radiologists. The size, localization of the tumor and possible infiltration of neighboring organs, as well as the presence of enlarged lymph nodes, were determined to define a preoperative, radiological TN stage. Lymph node metastasis was defined as peripancreatic lymphoma greater than 10 mm. Our findings were correlated to postoperative diagnosis.
RESULTS: The T-stage was correctly evaluated in 52.6% of the cases (10/19). Understaging took place in 31.6% (6/19) and overstaging in 15.8% (3/19). In three cases of understaging, a micro-infiltration of the peripancreatic tissue was not visible in MRI. Pathologically enlarged lymph nodes were correctly found in 63.2% of the cases (12/19). Overstaging took place in 21.1% of the cases (4/19) and understaging in 15.8% (3/19).
CONCLUSION: MRl for preoperative staging of pancreatic carcinoma showed a tendency to understage tumor size in this study population. Especially in cases of small tumor size, micro-infiltration of peripancreatic tissue or the common bile duct may not be detected by MRI. Concerning N-stage, the 95% confidence interval reveals a distribution of over- and understaged.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16277011

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  2 in total

1.  Preoperative diagnosis of lymph node metastasis in biliary and pancreatic carcinomas: evaluation of the combination of multi-detector CT and serum CA19-9 level.

Authors:  Atsushi Nanashima; Ichiro Sakamoto; Tomayoshi Hayashi; Syuuichi Tobinaga; Masato Araki; Masaki Kunizaki; Takashi Nonaka; Hiroaki Takeshita; Shigekazu Hidaka; Terumitsu Sawai; Toru Yasutake; Takeshi Nagayasu
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

2.  Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer.

Authors:  Hye Jin Choi; Chang Moo Kang; Woo Jung Lee; Si Young Song; Arthur Cho; Mijin Yun; Jong Doo Lee; Joo Hang Kim; Jae-Hoon Lee
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.